A press release from Skyhawk Therapeutics announces nine month interim results in patients from its Phase 1 clinical trial of SKY-0515 as a treatment for Huntington’s Disease. See the full…
Menifee City Disabilities Fair
The Menifee City Disabilities Fair, sponsored by the city of Menifee November 8th, 2025: UCI HD-CARE board member Leslie Frias was there to raise awareness for Huntington Disease research at…
One of the highlights in 2025 for President Emeritus Frances Saldana - representing HD-CARE at the HSG Clinical Congress in Tennessee and promoting her book: Falling Angels - A Rhapsody…
HD Hero Sarah Tabrizi as One of Nature’s 10
Huntington disease researcher Dr. Sarah Tabrizi was named one of Nature's 10: Ten people who helped shape science in 2025 Full article: https://hdfoundation.org/wp-content/uploads/2025/12/Natures-10-2025.pdf?bbeml=tp-kOgnhSY2TESsVKneKkvHVw.jpYuoxtPSWEC1xT8c_1Qc5A.r_YWdi7howEK7tH93l09m-Q.lJ1AInFUl6EWc4ZKWCHoE7w
New Memoir: “FALLING ANGELS – A Rhapsody of DNA, And A Family At War With Huntington’s Disease”
Sheds Light on the Silent Struggle of Families Battling Huntington’s Disease (Temecula, CA) — In her deeply moving and unflinchingly honest memoir, FALLING ANGELS - A Rhapsody of DNA, and…
HD successfully treated for first time
BBC News reports on early clinical trial results of a gene therapy delivered directly into the brain to lower mutant huntingtin. Patients treated so far show signs of slower disease…
Oxytocin in Huntington’s Disease and ALS-FTD
The journal Frontiers in Molecular Neuroscience spotlights a comprehensive review titled “Oxytocin in Huntington’s disease and the spectrum of amyotrophic lateral sclerosis–frontotemporal dementia” by Bergh et al. The article shares…